Acrobiosystems Co.,Ltd. (SZSE: 301080)
Health Care · Biotechnology · CN
CN¥141.07
+16.19% today · +128.7% 1Y
Acrobiosystems Co.,Ltd. (SZSE: 301080) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.52B.
Over the last twelve months the share price has gained 128.7%, trading between 35.87 and 141.07.
Tweenvest scores Acrobiosystems Co.,Ltd. across four factors: quality 71/100, value 21/100, growth 88/100, dividend 32/100. Its strongest factor is growth.
301080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.52B
- Revenue (TTM)
- $139.90M
- P/E
- 131.00
- EPS
- 1.08
- Dividend yield
- 0.43%
- Beta (5Y)
- 0.64
- 52-week high
- CN¥141.07
- 52-week low
- CN¥35.87
- Avg volume (3M)
- —
- Shares outstanding
- 167.18M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xenon Pharmaceuticals Inc.NasdaqGM: XENE | $3.68B | $36.14 | -4.94% |
| InnoCare Pharma LimitedSEHK: 9969 | $3.67B | HK$13.63 | -4.62% |
| Hualan Biological Engineering Inc.SZSE: 002007 | $3.63B | CN¥13.34 | +1.75% |
| Celcuity Inc.NasdaqCM: CELC | $3.53B | $67.85 | -5.89% |
| IDEAYA Biosciences, Inc.NasdaqGS: IDYA | $3.50B | $36.05 | -0.58% |
| Veracyte, Inc.NasdaqGM: VCYT | $3.47B | $43.60 | +1.02% |
| Walvax Biotechnology Co., Ltd.SZSE: 300142 | $3.39B | CN¥14.23 | +4.79% |
| Acadia Pharmaceuticals Inc.NasdaqGS: ACAD | $3.39B | $19.57 | -0.41% |
Figures last refreshed Oct 4, 2026.